(AHA) scientific statement “Treatment of Hypertension in the Prevention and Management of
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …

Duchenne muscular dystrophy (DMD) is a severe, progressive disease that affects 1 in 3600–
6000 live male births. Although guidelines are available for various aspects of DMD …

Background: Dyspnea is a common, distressing symptom of cardiopulmonary and
neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in …

This document was written with the intent to be a complete reference at the time of
publication on the topic of managing hypertension in the elderly. Given the length of the …

Optimum management of Duchenne muscular dystrophy (DMD) requires a multidisciplinary
approach that focuses on anticipatory and preventive measures as well as active …

Classifications of heart muscle diseases have proved to be exceedingly complex and in
many respects contradictory. Indeed, the precise language used to describe these diseases …

Objective: Older people experience more concurrent illnesses, are prescribed more
medications and suffer more adverse drug events than younger people. Many drugs …

The American Heart Association and the American Association of Cardiovascular and
Pulmonary Rehabilitation recognize that all cardiac rehabilitation/secondary prevention …

Objectives: We sought to determine the effects of cardiac resynchronization therapy (CRT) in
New York Heart Association (NYHA) functional class II heart failure (HF) and NYHA …

The changes in left ventricular (LV) structure and geometry that evolve after myocardial
injury or overload usually involve chamber dilation and/or hypertrophy. Such architectural …